Document Type
Journal Article
Publication Date
1-1-2017
Journal
PLoS One
Volume
12
Issue
9
DOI
10.1371/journal.pone.0181004
Abstract
Hepatitis C virus infection induces inflammation and while it is believed that HIV co-infection enhances this response, HIV control may reduce inflammation and liver fibrosis in resolved or viremic HCV infection. Measurement of systemic biomarkers in co-infection could help define the mechanism of inflammation on fibrosis and determine if HIV control reduces liver pathology. A nested case-control study was performed to explore the relationship of systemic biomarkers of inflammation with liver fibrosis in HCV viremic and/or seropositive women with and without HIV infection. Serum cytokines, chemokines, growth factors and cell adhesion molecules were measured in HIV uninfected (HIV-, n = 18), ART-treated HIV-controlled (ARTc, n = 20), uncontrolled on anti-retroviral therapy (ARTuc, n = 21) and elite HIV controllers (Elite, n = 20). All were HCV seroreactive and had either resolved (HCV RNA-; <50IU/mL) or had chronic HCV infection (HCV RNA+). In HCV and HIV groups, aspartate aminotransferase to platelet ratio (APRI) was measured and compared to serum cytokines, chemokines, growth factors and cell adhesion molecules. APRI correlated with sVCAM, sICAM, IL-10, and IP-10 levels and inversely correlated with EGF, IL-17, TGF-α and MMP-9 levels. Collectively, all HCV RNA+ subjects had higher sVCAM, sICAM and IP-10 compared to HCV RNA-. In the ART-treated HCV RNA+ groups, TNF-α, GRO, IP-10, MCP-1 and MDC were higher than HIV-, Elite or both. In ARTuc, FGF-2, MPO, soluble E-selectin, MMP-9, IL-17, GM-CSF and TGF-α are lower than HIV-, Elite or both. Differential expression of soluble markers may reveal mechanisms of pathogenesis or possibly reduction of fibrosis in HCV/HIV co-infection.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
APA Citation
Keating, S., Dodge, J., Norris, P., Heitman, J., Gange, S., French, A., Glesby, M., Edlin, B., Latham, P., Villacres, M., Greenblatt, R., & Peters, M. (2017). The effect of HIV infection and HCV viremia on Inflammatory Mediators and Hepatic Injury-The Women's Interagency HIV Study.. PLoS One, 12 (9). http://dx.doi.org/10.1371/journal.pone.0181004
Peer Reviewed
1
Open Access
1
Included in
Hepatology Commons, Medical Pathology Commons, Pathology Commons, Virus Diseases Commons
Comments
Reproduced with permission of PLoS ONE